| Dr Gordon Charles Manin, MD | |
|
10 Top Of The Oaks, Chadds Ford, PA 19317-9147 | |
| (610) 558-1091 | |
| Not Available |
| Full Name | Dr Gordon Charles Manin |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
| Location | 10 Top Of The Oaks, Chadds Ford, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962534982 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | MD049587L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gordon Charles Manin, MD 10 Top Of The Oaks, Chadds Ford, PA 19317-9147 Ph: (610) 558-1091 | Dr Gordon Charles Manin, MD 10 Top Of The Oaks, Chadds Ford, PA 19317-9147 Ph: (610) 558-1091 |
News Archive
The American Association of Critical-Care Nurses will present the Flame of Excellence Award to Elizabeth Bridges, RN, PhD, CCNS, FCCM, FAAN — colonel, U.S. Air Force Reserves, associate professor at the University of Washington School of Nursing and a clinical nurse researcher at the University of Washington Medical Center, Seattle.
ince 2008, researchers at Boston University School of Medicine (BUSM) and VA Boston Healthcare System have studied Chronic Traumatic Encephalopathy (CTE), a progressive brain disease associated with repetitive head impacts that has been diagnosed after death in the brains of American football players and other contact sport athletes as well as members of the armed services.
American and European scientists have found that increasing natural marijuana-like chemicals in the brain can help correct behavioral issues related to fragile X syndrome, the most common known genetic cause of autism.
Researchers in Ohio and Rhode Island have identified two previously undescribed radiological signs of potentially life-threatening slippage of laparoscopically adjustable gastric bands.
Cellumen, Inc., a discovery and early safety assessment company, today announced that its in vitro Rat Hepatocyte Early Safety Assessment Panel provides increased predictivity for human drug induced liver injury (DILI) equivalent to that of a recently published panel comprised of human hepatocytes. The implications of this study have a significant impact on cost and throughput for in vitro human DILI predictive solutions.
› Verified 5 days ago